RAMM Pharma Statistics

Total Valuation

RAMM Pharma has a market cap or net worth of CAD 1.79 million. The enterprise value is 529,779.

Market Cap	1.79M
Enterprise Value	529,779

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

RAMM Pharma has 119.39 million shares outstanding. The number of shares has decreased by -1.98% in one year.

Current Share Class	n/a
Shares Outstanding	119.39M
Shares Change (YoY)	-1.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	27.18%
Owned by Institutions (%)	n/a
Float	86.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.40
PB Ratio	0.07
P/TBV Ratio	0.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.06
EV / Sales	0.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.11

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.01.

Current Ratio	3.48
Quick Ratio	1.78
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-155.93

Financial Efficiency

Return on equity (ROE) is -30.28% and return on invested capital (ROIC) is -14.38%.

Return on Equity (ROE)	-30.28%
Return on Assets (ROA)	-13.51%
Return on Capital (ROIC)	-14.38%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	1.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.43% in the last 52 weeks. The beta is -0.21, so RAMM Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-71.43%
50-Day Moving Average	0.01
200-Day Moving Average	0.03
Relative Strength Index (RSI)	53.94
Average Volume (20 Days)	44,409

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RAMM Pharma had revenue of CAD 4.47 million and -8.87 million in losses. Loss per share was -0.07.

Revenue	4.47M
Gross Profit	508,200
Operating Income	-6.82M
Pretax Income	-8.86M
Net Income	-8.87M
EBITDA	-6.14M
EBIT	-6.82M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 1.51 million in cash and 247,438 in debt, giving a net cash position of 1.26 million or 0.01 per share.

Cash & Cash Equivalents	1.51M
Total Debt	247,438
Net Cash	1.26M
Net Cash Per Share	0.01
Equity (Book Value)	25.53M
Book Value Per Share	0.21
Working Capital	4.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.77 million and capital expenditures -77,928, giving a free cash flow of -4.84 million.

Operating Cash Flow	-4.77M
Capital Expenditures	-77,928
Free Cash Flow	-4.84M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 11.37%, with operating and profit margins of -152.66% and -198.51%.

Gross Margin	11.37%
Operating Margin	-152.66%
Pretax Margin	-198.30%
Profit Margin	-198.51%
EBITDA Margin	-137.28%
EBIT Margin	-152.66%
FCF Margin	-108.37%

Dividends & Yields

RAMM Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.98%
Shareholder Yield	1.98%
Earnings Yield	-495.45%
FCF Yield	-270.45%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RAMM Pharma has an Altman Z-Score of -1.26. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.26
Piotroski F-Score	n/a